-
Je něco špatně v tomto záznamu ?
Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics
D. Munblit, M. Greenhawt, HA. Brough, A. Pushkareva, D. Karimova, A. Demidova, JO. Warner, O. Kalayci, A. Sediva, E. Untersmayr, P. Rodriguez Del Rio, M. Vazquez-Ortiz, S. Arasi, M. Alvaro-Lozano, S. Tsabouri, E. Galli, B. Beken, PA. Eigenmann
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
PubMed
36282136
DOI
10.1111/pai.13851
Knihovny.cz E-zdroje
- MeSH
- alergie * MeSH
- bronchiální astma * epidemiologie MeSH
- COVID-19 * epidemiologie MeSH
- dítě MeSH
- lidé MeSH
- pandemie MeSH
- postakutní syndrom COVID-19 MeSH
- syndromy imunologické nedostatečnosti * MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
By the April 12, 2022, the COVID-19 pandemic had resulted in over half a billion people being infected worldwide. There have been 6.1 million deaths directly due to the infection, but the pandemic has had many more short- and long-term pervasive effects on the physical and mental health of the population. Allergic diseases are among the most prevalent noncommunicable chronic diseases in the pediatric population, and health-care professionals and researchers were seeking answers since the beginning of pandemic. Children are at lower risk of developing severe COVID-19 or dying from infection. Allergic diseases are not associated with a higher COVID-19 severity and mortality, apart from severe/poorly controlled asthma. The pandemic disrupted routine health care, but many mitigation strategies, including but not limited to telemedicine, were successfully implemented to continue delivery of high-standard care. Although children faced a multitude of pandemic-related issues, allergic conditions were effectively treated remotely while reduction in air pollution and lack of contact with outdoor allergens resulted in improvement, particularly respiratory allergies. There is no evidence to recommend substantial changes to usual management modalities of allergic conditions in children, including allergen immunotherapy and use of biologicals. Allergic children are not at greater risk of multisystem inflammatory syndrome development, but some associations with Long COVID were reported, although the data are limited, and further research is needed. This statement of the EAACI Section on Pediatrics provides recommendations based on the lessons learnt from the pandemic, as available evidence.
Allergy Department Hospital Infantil Universitario Niño Jesus Madrid Spain
Child Health Department University of Ioannina School of Medicine Ioannina Greece
Children's Allergy Service Evelina Children's Hospital Guy's and St Thomas' Hospital London UK
European Academy of Allergy and Clinical Immunology Zurich Switzerland
Pediatric Allergy and Asthma School of Medicine Hacettepe University Ankara Turkey
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22033137
- 003
- CZ-PrNML
- 005
- 20241217095445.0
- 007
- ta
- 008
- 230120s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/pai.13851 $2 doi
- 035 __
- $a (PubMed)36282136
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Munblit, Daniel $u Inflammation, Repair and Development Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK $1 https://orcid.org/0000000196526856
- 245 10
- $a Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics / $c D. Munblit, M. Greenhawt, HA. Brough, A. Pushkareva, D. Karimova, A. Demidova, JO. Warner, O. Kalayci, A. Sediva, E. Untersmayr, P. Rodriguez Del Rio, M. Vazquez-Ortiz, S. Arasi, M. Alvaro-Lozano, S. Tsabouri, E. Galli, B. Beken, PA. Eigenmann
- 520 9_
- $a By the April 12, 2022, the COVID-19 pandemic had resulted in over half a billion people being infected worldwide. There have been 6.1 million deaths directly due to the infection, but the pandemic has had many more short- and long-term pervasive effects on the physical and mental health of the population. Allergic diseases are among the most prevalent noncommunicable chronic diseases in the pediatric population, and health-care professionals and researchers were seeking answers since the beginning of pandemic. Children are at lower risk of developing severe COVID-19 or dying from infection. Allergic diseases are not associated with a higher COVID-19 severity and mortality, apart from severe/poorly controlled asthma. The pandemic disrupted routine health care, but many mitigation strategies, including but not limited to telemedicine, were successfully implemented to continue delivery of high-standard care. Although children faced a multitude of pandemic-related issues, allergic conditions were effectively treated remotely while reduction in air pollution and lack of contact with outdoor allergens resulted in improvement, particularly respiratory allergies. There is no evidence to recommend substantial changes to usual management modalities of allergic conditions in children, including allergen immunotherapy and use of biologicals. Allergic children are not at greater risk of multisystem inflammatory syndrome development, but some associations with Long COVID were reported, although the data are limited, and further research is needed. This statement of the EAACI Section on Pediatrics provides recommendations based on the lessons learnt from the pandemic, as available evidence.
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a COVID-19 $x epidemiologie $7 D000086382
- 650 _2
- $a pandemie $7 D058873
- 650 12
- $a alergie $7 D006967
- 650 12
- $a bronchiální astma $x epidemiologie $7 D001249
- 650 12
- $a syndromy imunologické nedostatečnosti $7 D007153
- 650 _7
- $a postakutní syndrom COVID-19 $7 D000094024 $2 czmesh
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Greenhawt, Matthew $u Section of Allergy and Clinical Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado, USA $1 https://orcid.org/0000000223659372
- 700 1_
- $a Brough, Helen A $u Children's Allergy Service, Evelina Children's Hospital, Guy's and St. Thomas' Hospital, London, UK $u Paediatric Allergy Group, Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK
- 700 1_
- $a Pushkareva, Anna $u European Academy of Allergy and Clinical Immunology (EAACI), Zurich, Switzerland
- 700 1_
- $a Karimova, Diana $u European Academy of Allergy and Clinical Immunology (EAACI), Zurich, Switzerland
- 700 1_
- $a Demidova, Anastasia $u European Academy of Allergy and Clinical Immunology (EAACI), Zurich, Switzerland
- 700 1_
- $a Warner, John O $u Inflammation, Repair and Development Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK $1 https://orcid.org/0000000171236369
- 700 1_
- $a Kalayci, Omer $u Pediatric Allergy and Asthma, School of Medicine, Hacettepe University, Ankara, Turkey $1 https://orcid.org/0000000187155694
- 700 1_
- $a Sediva, Anna $u Department of Immunology, 2nd Medical Faculty, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Untersmayr, Eva $u Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Rodriguez Del Rio, Pablo $u Allergy Department, Hospital Infantil Universitario Niño Jesus, Madrid, Spain
- 700 1_
- $a Vazquez-Ortiz, Marta $u Inflammation, Repair and Development Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK
- 700 1_
- $a Arasi, Stefania $u Translational Research in Pediatric Specialities Area, Division of Allergy, IRCCS, Bambino Gesù Children's Hospital, Rome, Italy $1 https://orcid.org/0000000281350568
- 700 1_
- $a Alvaro-Lozano, Montserrat $u Allergology and Clinical Immunology Department, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain
- 700 1_
- $a Tsabouri, Sophia $u Child Health Department, University of Ioannina School of Medicine, Ioannina, Greece $1 https://orcid.org/0000000175845401
- 700 1_
- $a Galli, Elena $u Pediatric Allergology Unit, Department of Pediatric Medicine, S.Pietro Hospital Fatebenefratelli, Rome, Italy $1 https://orcid.org/0000000166929101
- 700 1_
- $a Beken, Burcin $u Department of Pediatric Allergy and Immunology, Acibadem University School of Medicine, Istanbul, Turkey $1 https://orcid.org/0000000176777690
- 700 1_
- $a Eigenmann, Philippe $u Pediatric Allergy Unit, Department of Woman, Child and Adolescent, University Hospitals of Geneva, Geneva, Switzerland $1 https://orcid.org/0000000317381826 $7 xx0326824
- 773 0_
- $w MED00010395 $t Pediatric allergy and immunology $x 1399-3038 $g Roč. 33, č. 10 (2022), s. e13851
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36282136 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20241217095441 $b ABA008
- 999 __
- $a ok $b bmc $g 1891728 $s 1184472
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 33 $c 10 $d e13851 $e - $i 1399-3038 $m Pediatric allergy and immunology $n Pediatr Allergy Immunol $x MED00010395
- LZP __
- $a Pubmed-20230120
